Title: Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland.
Journal: Breast cancer research and treatment 20120701
Title: Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice.
Journal: Molecular and cellular endocrinology 20100514
Title: Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Journal: Journal of medicinal chemistry 20091210
Title: Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor alpha.
Journal: Molecular cancer therapeutics 20070501
Title: Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells.
Journal: Steroids 20061101
Title: The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061001
Title: Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.
Journal: Metabolism: clinical and experimental 20060501
Title: Estrogen receptor alpha-mediated adiposity-lowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene.
Journal: International journal of obesity (2005) 20051001
Title: Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina.
Journal: The Journal of steroid biochemistry and molecular biology 20050701
Title: Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors.
Journal: Journal of lipid research 20050601
Title: Synthesis and structure-activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution.
Journal: Journal of enzyme inhibition and medicinal chemistry 20050401
Title: Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
Journal: Chemical research in toxicology 20050201
Title: The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
Journal: The Journal of steroid biochemistry and molecular biology 20040901
Title: Selective estrogen receptor modulator regulated proteins in endometrial cancer cells.
Journal: Molecular and cellular endocrinology 20040430
Title: The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?
Journal: Endocrinology 20031101
Title: Good versus evil: changing the approach to hormone replacement therapy.
Journal: Endocrinology 20031101
Title: A novel pure SERM achieves complete regression of the majority of human breast cancer tumors in nude mice.
Journal: Breast cancer research and treatment 20031001
Title: Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Journal: Molecular endocrinology (Baltimore, Md.) 20030401
Title: The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
Journal: Obesity research 20030301
Title: Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
Journal: The Journal of steroid biochemistry and molecular biology 20030301
Title: Acute vascular effects of the selective estrogen receptor modulator EM-652 (SCH 57068) in the rat mesenteric vascular bed.
Journal: Cardiovascular research 20030201
Title: Estradiol reduces F2alpha-isoprostane production in cultured human endothelial cells.
Journal: American journal of physiology. Heart and circulatory physiology 20021201
Title: Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator.
Journal: Endocrinology 20020601
Title: Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
Journal: International journal of cancer 20020510
Title: Effects of the new generation selective estrogen receptor modulator EM-652 and oral administration of estradiol valerate on circulating, brain, and adrenal beta-endorphin and allopregnanolone levels in intact fertile and ovariectomized rats.
Journal: Fertility and sterility 20020501
Title: Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.
Journal: Clinical breast cancer 20020101
Title: Inhibition of low-density lipoprotein oxidation by the pure antiestrogens ICI 182780 and EM-652 (SCH 57068).
Journal: Menopause (New York, N.Y.) 20020101
Title: EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: Pure antiestrogens and breast cancer.
Journal: Current medical research and opinion 20010101
Title: The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.
Journal: Biological chemistry 19991101
Title: Wang T, et al. Recent advances in selective estrogen receptor modulators for breast cancer. Mini Rev Med Chem. 2009 Sep;9(10):1191-201.
Title: Christian Lemieux, et al. The selective estrogen receptor modulator acolbifene reduces cholesterolemia independently of its anorectic action in control and cholesterol-fed rats. J Nutr. 2005 Sep;135(9):2225-9.
Title: A Tremblay, et al. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta. Endocrinology. 1998 Jan;139(1):111-8.
Title: Sylvain Gauthier, et al. Synthesis and structure-activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution. J Enzyme Inhib Med Chem. 2005 Apr;20(2):165-77.
Title: F Labrie, et al. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol. Apr-Jun 1999;69(1-6):51-84.
